The U.S. tissue diagnostics market size was valued at USD 2.07 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 3.91% from 2021 to 2028. The market is collectively driven by emerging solutions pertaining to digital tissue diagnostics, advancements in imaging techniques & increasing affordability of diagnostics, and growth of personalized therapeutics & diagnostics. The use of digital slides has significantly increased in recent years, owing to its associated benefits including flexible magnification and remote access to slides.
Companies are supporting the development of precision medicine with novel oncology solutions. For instance, in May 2020, QIAGEN launched new oncology solutions, such as the QCI Interpret One software solution for genomic profiling of tumors. The advancements in imaging techniques are expected to positively influence the market growth. According to Breastcancer.org, breast cancer is the most common type of cancer diagnosed among American women. In 2021, it is estimated that around 30% of the new cases of cancer in women would be breast cancers.
Key Player Mentioned:
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Danaher
- bioMérieux SA
- QIAGEN
- Becton, Dickinson & Company (BD)
- Agilent Technologies, Inc.
- General Electric Company (GE Healthcare)
- BioGenex
To identify the key drivers and the competitors’ insights, Request a Sample @:
https://www.grandviewresearch.com/industry-analysis/us-tissue-diagnostics-market/request/rs1
Product Segment Analysis:
- Breast Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Prostate Cancer
- Gastric Cancer
- Other Cancers
Regional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa
With technological improvements in imaging techniques, the sensitivity of detection and diagnosis of breast cancer has also improved. Technological expansion in breast tissue analysis includes procedures for evaluating gene expression, cellular biochemistry, and molecular biology using digital methods, tomosynthesis, CAD, and other methods. The global COVID-19 pandemic has affected several aspects in pathology laboratories, such as specimen workflow, biosafety protocols, laboratory staffing, laboratory finances, and resident training.
Access Press Release: https://www.grandviewresearch.com/press-release/us-tissue-diagnostics-market-analysis
The specimens for histology were collected and processed by standard procedures involving embedding in paraffin, and later staining with hematoxylin and eosin. However, the presence of a non-value-based reimbursement policy and high costs associated with the usage of tissue diagnosis is anticipated to act as a restraint for the market. Several factors are contributing to the high cost of clinical research in the U.S. including administrative staff costs, clinical procedure costs, and site monitoring costs.
Why Purchase this Report?
- A strong research methodology was followed to collect data for the report. The data collected in this way are subjected to several quality checks to provide the best quality.
- The report provides a holistic view of the competitive scenario of the U.S. Tissue Diagnostics market.
- The latest product launches, along with technological changes and developments, are included in the report.
- The data analysis in the report will help you understand the U.S. Tissue Diagnostics market dynamics projected from 2021 to 2028.
- The Report has a vast data store, so it can accommodate your custom needs as well.
About Us:
Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world’s renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.
